Novel compounds target formation of amyloid peptides

08/4/2013 | Yahoo

A study published in Nature Communications has uncovered the mechanisms behind two types of compounds that could help fight Alzheimer's disease. Researchers are testing the two compounds to target gamma secretase, the enzyme that cuts longer proteins into components including the form of amyloid peptide that aggregates into toxic plaques. The latest research helps explain how the new compounds interact with gamma secretase.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC